Pathstone Family Office LLC Has $715,000 Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Pathstone Family Office LLC lifted its stake in ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 37.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,742 shares of the medical instruments supplier’s stock after acquiring an additional 1,284 shares during the period. Pathstone Family Office LLC’s holdings in ICU Medical were worth $715,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ICUI. Wellington Management Group LLP grew its stake in shares of ICU Medical by 71.6% in the first quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier’s stock worth $337,542,000 after acquiring an additional 632,609 shares during the last quarter. River Road Asset Management LLC acquired a new stake in shares of ICU Medical in the third quarter worth $43,016,000. Vanguard Group Inc. grew its stake in shares of ICU Medical by 8.8% in the first quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier’s stock worth $472,466,000 after acquiring an additional 171,851 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of ICU Medical by 627.0% in the third quarter. The Manufacturers Life Insurance Company now owns 122,513 shares of the medical instruments supplier’s stock worth $18,450,000 after acquiring an additional 105,662 shares during the last quarter. Finally, Eaton Vance Management grew its stake in shares of ICU Medical by 45.4% in the first quarter. Eaton Vance Management now owns 265,343 shares of the medical instruments supplier’s stock worth $59,077,000 after acquiring an additional 82,861 shares during the last quarter. Institutional investors and hedge funds own 93.88% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised ICU Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, March 8th.

Insider Buying and Selling

In other ICU Medical news, VP Daniel Woolson sold 1,731 shares of ICU Medical stock in a transaction on Thursday, February 2nd. The stock was sold at an average price of $200.00, for a total transaction of $346,200.00. Following the completion of the transaction, the vice president now directly owns 9,152 shares of the company’s stock, valued at $1,830,400. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 7.30% of the stock is owned by company insiders.

ICU Medical Stock Up 2.0 %

Shares of ICUI stock opened at $156.20 on Tuesday. The stock has a market cap of $3.75 billion, a P/E ratio of -50.06 and a beta of 0.61. ICU Medical, Inc. has a one year low of $128.90 and a one year high of $251.73. The stock has a fifty day moving average price of $176.07 and a 200 day moving average price of $162.14. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.50 and a quick ratio of 1.09.

About ICU Medical

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.